1. A leave-one-out cross-validation SAS macro for the identification of markers associated with survival. (1st February 2015) Authors: Rushing, Christel; Bulusu, Anuradha; Hurwitz, Herbert I.; Nixon, Andrew B.; Pang, Herbert Journal: Computers in biology and medicine Issue: Volume 57(2015) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. (23rd March 2018) Authors: Vlahovic, Gordana; Meadows, Kellen L.; Hatch, Ace J.; Jia, Jingquan; Nixon, Andrew B.; Uronis, Hope E.; Morse, Michael A.; Selim, M. Angelica; Crawford, Jeffrey; Riedel, Richard F.; Zafar, S. Yousuf; Howard, Leigh A.; O'Neill, Margot; Meadows, Jennifer J.; Haley, Sherri T.; Arrowood, Christy C.; ... Journal: Oncologist Issue: Volume 23:Number 7(2018) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abstract 68: Post Traumatic Stress Disorder and Associated Risk in Breast Cancer Patients. (April 2018) Authors: Yoho, Daniel J.; Ulrich, Elizabeth; Rushing, Christel; Atisha, Dunya Journal: Plastic and reconstructive surgery Issue: Volume 6(2018)Supplement 4S Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Patient Perspectives on the Financial Costs and Burdens of Breast Cancer Surgery. Issue 6 (June 2021) Authors: Oshima, Sachiko M.; Tait, Sarah D.; Rushing, Christel; Lane, Whitney; Hyslop, Terry; Offodile, Anaeze C.; Wheeler, Stephanie B.; Zafar, S. Yousuf; Greenup, Rachel; Fish, Laura J. Journal: JCO oncology practice Issue: Volume 17:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients. (4th November 2015) Authors: Morse, Michael A; Hobeika, Amy; Gwin, William; Osada, Takuya; Gelles, Jonathan; Rushing, Christel; Niedzwiecki, Donna; Lyerly, H Kim Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗